熱門資訊> 正文
Arvinas任命Andrew Saik为首席财务官
2024-06-25 04:41
- Arvinas (NASDAQ:ARVN) on Monday announced the appointment of Andrew Saik to the role of Chief Financial Officer and Treasurer.
- Saik, most recently, served as CFO at Intercept Pharmaceuticals. Prior to Intercept Pharmaceuticals, he was CFO of Vyne Therapeutics.
- Source: Press Release
More on Arvinas
- Arvinas And Novartis Partnering On Prostate Cancer Protein Degrader Is A Win-Win Situation
- Financial information for Arvinas
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。